ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Biodesix Inc

Biodesix Inc (BDSX)

0.9951
0.0321
( 3.33% )
Updated: 13:39:50

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.050.050.050.050.000.00 %0472-
5.000.051.900.050.9750.000.00 %01-

Professional-Grade Tools, for Individual Investors.

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.252.800.001.5250.000.00 %00-
5.003.904.200.004.050.000.00 %00-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
$ 5.88
(127.91%)
93.4M
WRDWeRide Inc
$ 31.5999
(84.04%)
18.3M
SRMSRM Entertainment Inc
$ 0.6405
(78.91%)
228.93M
MBRXMoleculin Biotech Inc
$ 2.1449
(68.89%)
123.44M
SPGCSacks Parente Golf Inc
$ 0.96
(61.24%)
114.26M
NEXNNexxen International Ltd
$ 10.2296
(-49.51%)
84.28k
BSLKBolt Projects Holdings Inc
$ 0.6299
(-48.79%)
11.16M
BLACBellevue Life Sciences Acquisition Corporation
$ 3.7615
(-46.65%)
191.14k
BLACUBellevue Life Sciences Acquisition Corporation
$ 4.00
(-43.66%)
1.95k
SERVServe Robotics Inc
$ 13.1597
(-42.58%)
45.41M
CNSPCNS Pharmaceuticals Inc
$ 0.1379
(27.92%)
446.39M
MGOLMGO Global Inc
$ 0.7659
(-9.36%)
326.2M
SRMSRM Entertainment Inc
$ 0.6405
(78.91%)
228.93M
SOUNSoundHound AI Inc
$ 10.645
(-30.20%)
145.92M
INTCIntel Corporation
$ 23.4725
(-2.72%)
140.4M

BDSX Discussion

View Posts
georgie18 georgie18 1 month ago
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
๐Ÿ‘๏ธ0
PonkenPlonken PonkenPlonken 2 months ago
Mr Schuler is buying shares again
๐Ÿ‘๏ธ0
tw0122 tw0122 3 months ago
Is selling $250 million in stock fro time to time on the downside.. Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.
๐Ÿ‘๏ธ0
tw0122 tw0122 3 months ago
Lung diagnostics cancer revenues improving still has $33m cash $1.49 +'14%
๐Ÿ‘๏ธ0
AJ Freely AJ Freely 2 years ago
$BDSX - Up 12%/ Current Price $1.34.
Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
๐Ÿ‘๏ธ0
1hot toddy 1hot toddy 2 years ago
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$
๐Ÿ‘๏ธ0
Leg58 Leg58 2 years ago
Lots if potential but will public offering dilute price?
๐Ÿ‘๏ธ0
Leg58 Leg58 2 years ago
Lots if potential but will public offering dilute price?
๐Ÿ‘๏ธ0
subslover subslover 2 years ago
Earnings look good.
๐Ÿ‘๏ธ0
subslover subslover 2 years ago
Earnings look good.
๐Ÿ‘๏ธ0
MiamiGent MiamiGent 2 years ago
BDSX Has news this morning!

The contract covers the companyโ€™s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGSโ„ข testing.

https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

https://stockcharts.com/h-sc/ui?s=BDSX
๐Ÿ‘๏ธ0
carusso carusso 2 years ago
Not so much...
๐Ÿ‘๏ธ0
crudeoil24 crudeoil24 2 years ago
LET'S GO BDSX !!!!!
๐Ÿ‘๏ธ0
crudeoil24 crudeoil24 2 years ago
Biodesix to Participate in Two Upcoming Investor Conferences in September
6:00 am ET September 6, 2022 (BusinessWire) Print
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY
๐Ÿ‘๏ธ0
crudeoil24 crudeoil24 2 years ago
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Companyโ€™s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
๐Ÿ‘๏ธ0
Leg58 Leg58 3 years ago
US based company is quietly trending up. IMHO.
GLTA
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock